Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

WTL Lo, D Ki‐Yan Mak… - CNS neuroscience & …, 2021 - Wiley Online Library
Recent research on second‐generation long‐acting injectable antipsychotics (LAI SGAs)
has proven its effectiveness in minimizing medication nonadherence problem and reducing …

[HTML][HTML] Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

DKY Mak, MMC Wong, OW Chan… - CNS Neuroscience & …, 2021 - ncbi.nlm.nih.gov
Recent research on second‐generation long‐acting injectable antipsychotics (LAI SGAs)
has proven its effectiveness in minimizing medication nonadherence problem and reducing …

Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

WTL Lo, DKY Mak, MMC Wong, OW Chan… - CNS Neuroscience & …, 2021 - infona.pl
Recent research on second‐generation long‐acting injectable antipsychotics (LAI SGAs)
has proven its effectiveness in minimizing medication nonadherence problem and reducing …

Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

WAL Lo, DKY Mak, MMC Wong… - CNS neuroscience …, 2021 - pubmed.ncbi.nlm.nih.gov
Recent research on second-generation long-acting injectable antipsychotics (LAI SGAs) has
proven its effectiveness in minimizing medication nonadherence problem and reducing …

Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence.

WA Lo, OW Chan, KS Lau, CK Lee, J Mui… - CNS Neuroscience & …, 2021 - europepmc.org
Recent research on second‐generation long‐acting injectable antipsychotics (LAI SGAs)
has proven its effectiveness in minimizing medication nonadherence problem and reducing …

Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

DKY Mak, MMC Wong, OW Chan… - CNS Neuroscience …, 2021 - search.proquest.com
Recent research on second‐generation long‐acting injectable antipsychotics (LAI SGAs)
has proven its effectiveness in minimizing medication nonadherence problem and reducing …

[PDF][PDF] Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

WTL Lo, DKY Mak, MMC Wong, OW Chan, EMC Chui… - 2021 - researchgate.net
Recent research on second-generation long-acting injectable antipsychotics (LAI SGAs) has
proven its effectiveness in minimizing medication nonadherence problem and reducing …

Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence.

WTL Lo, D Ki‐Yan Mak… - CNS Neuroscience & …, 2021 - psycnet.apa.org
Abstract [Correction Notice: An Erratum for this article was reported in Vol 27 (10) of CNS
Neuroscience & Therapeutics (see record 2021-87044-003). The name of the first author …

Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

WTL Lo, DKY Mak, MMC Wong… - CNS Neuroscience …, 2021 - search.proquest.com
Recent research on second‐generation long‐acting injectable antipsychotics (LAI SGAs)
has proven its effectiveness in minimizing medication nonadherence problem and reducing …

[PDF][PDF] Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence

WTL Lo, DKY Mak, MMC Wong, OW Chan, EMC Chui… - 2021 - researchgate.net
Recent research on second-generation long-acting injectable antipsychotics (LAI SGAs) has
proven its effectiveness in minimizing medication nonadherence problem and reducing …